{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:40:25Z","timestamp":1768344025111,"version":"3.49.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Hospital Organization.","award":["H29-NHO-01"],"award-info":[{"award-number":["H29-NHO-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver damage progresses to cirrhosis or hepatocellular carcinoma (HCC). The mainstay therapy for AIH is steroids and other immunosuppressive treatments. Currently, there are no validated markers for monitoring immune-mediated hepatic inflammation. Galectin-9 has recently been identified as a potential biomarker in patients with chronic liver disease. The objective of this study was to determine whether Galectin-9 and other serum proteins are associated with active disease in AIH patients.<\/jats:p>\n            <jats:p>We enrolled 77 Japanese patients with well-documented AIH who were identified from the National Hospital Organization-AIH-liver-network database, as well as 32 patients with chronic hepatitis C (CHC), 27 patients with SLE, and 17 healthy control subjects. Serum levels of galectin-9, and markers of liver injury were measured and compared between groups.<\/jats:p>\n            <jats:p>Serum levels of galectin-9 were significantly higher in AIH patients than in CHC patients (13.8\u200a\u00b1\u200a4.9\u200ang\/mL vs 8.9\u200a\u00b1\u200a3.0\u200ang\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) or healthy controls (13.8\u200a\u00b1\u200a4.9\u200ang\/mL vs 5.0\u200a\u00b1\u200a1.3\u200ang\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). In AIH group, serum galectin-9 levels weakly correlated with alanine aminotransferase levels or total bilirubin (TB) and strongly correlated with C\u2013X\u2013C motif chemokine 10 (CXCL10) and Mac-2 binding protein glycosylation isomer (M2BPGi) levels, but did not correlate with the histological grade of liver fibrosis. Steroid treatment of AIH patients significantly reduced serum galectin-9 levels (14.1\u200a\u00b1\u200a4.9\u200ang\/mL vs 8.3\u200a\u00b1\u200a3.8\u200ang\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). SLE patients exhibited higher galectin-9 levels, whereas the galectin-9 levels did not correlate with liver function tests such as alanine aminotransferase levels.<\/jats:p>\n            <jats:p>Serum galectin-9 correlated with disease status in AIH patients and could thus be useful biomarkers to detect hepatic autoimmunity. Because circulating galectin-9 reflects autoimmune-mediated inflammation, it may have additional utility as a biomarker for other autoimmune disorders.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000016924","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T14:30:50Z","timestamp":1567089050000},"page":"e16924","source":"Crossref","is-referenced-by-count":15,"title":["Galectin-9 in autoimmune hepatitis"],"prefix":"10.1097","volume":"98","author":[{"given":"Naoki","family":"Matsuoka","sequence":"first","affiliation":[{"name":"Clinical Research Center, Nagasaki Medical Center, Nagasaki"},{"name":"Department of Rheumatology, Fukushima Medical University, Fukushima"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Kozuru","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Nagasaki Medical Center, Nagasaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Unit of Translational Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Abiru","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Nagasaki Medical Center, Nagasaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Nagasaki Medical Center, Nagasaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsumasa","family":"Komori","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Nagasaki Medical Center, Nagasaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University, Fukushima"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpei","family":"Tenmoku","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University, Fukushima"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University, Fukushima"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University, Fukushima"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University, Fukushima"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Furuya","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University, Fukushima"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University, Fukushima"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University, Fukushima"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Naganuma","sequence":"additional","affiliation":[{"name":"National Hospital Organization, Takasaki Medical Center, Takasaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaname","family":"Yoshizawa","sequence":"additional","affiliation":[{"name":"National Hospital Organization, Shinsyu-Ueda Medical Center, Ueda, Nagano"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Shimada","sequence":"additional","affiliation":[{"name":"National Hospital Organization, Nagoya Medical Center, Nagoya, Aichi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Ario","sequence":"additional","affiliation":[{"name":"National Hospital Organization, Ureshino Medical Center, Ureshino, Saga"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiro","family":"Yamashita","sequence":"additional","affiliation":[{"name":"National Hospital Organization, Okayama Medical Center, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kohno","sequence":"additional","affiliation":[{"name":"National Hospital Organization, Kure Medical Center, Kure"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Kaneyoshi","sequence":"additional","affiliation":[{"name":"National Hospital Organization, Fukuyama Medical Center, Fukuyama, Hiroshima"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University, Fukushima, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Unit of Translational Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University, Fukushima, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yatsuhashi","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Nagasaki Medical Center, Nagasaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Nagasaki Medical Center, Nagasaki"},{"name":"Department of Rheumatology, Fukushima Medical University, Fukushima"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hep.29106","article-title":"Galectin-9: diverse roles in hepatic immune homeostasis and inflammation","volume":"66","author":"Golden-Mason","year":"2017","journal-title":"Hepatology"},{"key":"R2-20230914","first-page":"1","article-title":"TIM-3 and its regulatory role in immune responses","volume":"350","author":"Zhu","year":"2011","journal-title":"Curr Top Microbiol Immunol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.coi.2006.09.009","article-title":"TIM-3 in autoimmunity","volume":"18","author":"Anderson","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clim.2008.01.006","article-title":"Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis","volume":"127","author":"Seki","year":"2008","journal-title":"Clin Immunol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"34","author":"Longhi","year":"2010","journal-title":"J Autoimmun"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/hep.25777","article-title":"Tim-3\/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma","volume":"56","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cgh.2015.09.040","article-title":"Association between plasma level of galectin-9 and survival of patients with drug-induced acute liver failure","volume":"14","author":"Rosen","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1189\/jlb.5A1214-582R","article-title":"HCV-infected cells and differentiation increase monocyte immunoregulatory galectin-9 production","volume":"99","author":"Harwood","year":"2016","journal-title":"J Leukoc Biol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3892\/mmr.2017.6606","article-title":"Galectin\u20139 ameliorates fulminant liver injury","volume":"16","author":"Tadokoro","year":"2017","journal-title":"Mol Med Rep"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/jgh.13851","article-title":"Correlation between serum galectin-9 levels and liver fibrosis","volume":"33","author":"Fujita","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1136\/annrheumdis-2018-213497","article-title":"Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome","volume":"77","author":"van den Hoogen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00535-010-0337-y","article-title":"Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study","volume":"46","author":"Migita","year":"2011","journal-title":"J Gastroenterol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.27305","article-title":"Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients","volume":"60","author":"Yamasaki","year":"2014","journal-title":"Hepatology"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.3748\/wjg.v21.i23.7165","article-title":"Activated rat hepatic stellate cells influence Th1\/Th2 profile in vitro","volume":"21","author":"Xing","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.0903275","article-title":"Tim-3\/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells","volume":"185","author":"Dardalhon","year":"2010","journal-title":"J Immunol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.4049\/jimmunol.0803673","article-title":"Role of Tim-3\/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators","volume":"182","author":"Sehrawat","year":"2009","journal-title":"J Immunol"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"e1273309","DOI":"10.1080\/2162402X.2016.1273309","article-title":"PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma","volume":"6","author":"Sideras","year":"2017","journal-title":"Oncoimmunology"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00535-017-1425-z","article-title":"Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis","volume":"53","author":"Shirabe","year":"2018","journal-title":"J Gastroenterol"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"e13450","DOI":"10.1097\/MD.0000000000013450","article-title":"Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis","volume":"97","author":"Migita","year":"2018","journal-title":"Medicine"},{"key":"R22-20230914","first-page":"177","article-title":"Galectin-9 in tumor biology: a jack of multiple trades","volume":"1836","author":"Heusschen","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.immuni.2014.06.011","article-title":"Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells","volume":"41","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/JLB.3VMR0118-036R","article-title":"Galectin-3-binding protein: a multitask glycoprotein with innate immunity functions in viral and bacterial infections","volume":"104","author":"Loimaranta","year":"2018","journal-title":"J Leukoc Biol"},{"key":"R26-20230914","article-title":"Serum galectin-9 and galectin-3-binding protein in acute Dengue virus infection","volume":"17","author":"Liu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"e1505","DOI":"10.1371\/journal.pntd.0001505","article-title":"Association of mast cell-derived VEGF and proteases in Dengue shock syndrome","volume":"6","author":"Furuta","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"9186940","DOI":"10.1155\/2018\/9186940","article-title":"The role of galectins as modulators of metabolism and inflammation","volume":"2018","author":"Brinchmann","year":"2018","journal-title":"Mediators Inflamm"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201908300-00040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:45:13Z","timestamp":1694727913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201908300-00040"}},"subtitle":["Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis"],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":29,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000016924","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}